That’s right—SVR and SVR24 (24 weeks after EoT) mean the same thing.
I don’t object to a company’s citing SVR12 data (12 weeks after EoT) if that’s the only data available for certain dosing cohorts in the reporting of a larger dataset. I do, however, question the kind of PR that ANDS issued yesterday, which could have been postponed until the SVR data are mature.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”